logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    De Rubertis, Francesco
    Born in January 1970
    Individual (19 offsprings)
    Officer
    2021-06-25 ~ now
    OF - Director → CIF 0
  • 2
    Ring, Robert
    Born in December 1967
    Individual (1 offspring)
    Officer
    2019-03-12 ~ now
    OF - Director → CIF 0
  • 3
    Mayer, Howard, Dr
    Born in August 1962
    Individual (1 offspring)
    Officer
    2024-05-02 ~ now
    OF - Director → CIF 0
Ceased 8
  • 1
    Perche, Olivier
    Engineer born in November 1981
    Individual
    Officer
    2021-06-29 ~ 2023-04-26
    OF - Director → CIF 0
  • 2
    Zweifach, Sanford
    Company Director born in March 1956
    Individual
    Officer
    2021-02-09 ~ 2023-10-06
    OF - Director → CIF 0
  • 3
    Finet, Marie Henriette
    Scientific Officer born in November 1964
    Individual
    Officer
    2022-08-17 ~ 2024-05-02
    OF - Director → CIF 0
  • 4
    Vagner, Alex
    Director born in March 1959
    Individual
    Officer
    2017-04-21 ~ 2021-07-19
    OF - Director → CIF 0
  • 5
    Luthringer, Remy Henri
    Ceo born in November 1960
    Individual
    Officer
    2019-05-22 ~ 2021-07-14
    OF - Director → CIF 0
  • 6
    Sekhri, Paul
    Partner At Medicxi Ventures born in April 1958
    Individual
    Officer
    2023-10-06 ~ 2025-10-01
    OF - Director → CIF 0
  • 7
    Ollier, Michele
    Born in June 1958
    Individual (6 offsprings)
    Officer
    2016-07-12 ~ 2025-12-05
    OF - Director → CIF 0
  • 8
    TCPI ASSET 1 LIMITED - 2013-04-10
    25, Fiddle Bridge Lane, Hatfield, Hertfordshire, England
    Active Corporate (4 parents, 33 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2016-07-12 ~ 2017-12-03
    PE - Secretary → CIF 0
    Person with significant control
    2016-07-12 ~ 2016-10-14
    PE - Has significant influence or control → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

KAERUS BIOSCIENCE LIMITED

Previous name
FRAXADEV LIMITED - 2016-11-23
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
62024-01-01 ~ 2024-12-31
52023-01-01 ~ 2023-12-31
Fixed Assets - Investments
2 GBP2024-12-31
2 GBP2023-12-31
Debtors
Current
93,593 GBP2024-12-31
190,818 GBP2023-12-31
Cash at bank and in hand
2,055,366 GBP2024-12-31
2,483,729 GBP2023-12-31
Current Assets
2,148,959 GBP2024-12-31
2,674,547 GBP2023-12-31
Net Current Assets/Liabilities
1,831,987 GBP2024-12-31
2,076,648 GBP2023-12-31
Net Assets/Liabilities
1,831,989 GBP2024-12-31
2,076,650 GBP2023-12-31
Equity
Called up share capital
742,325 GBP2024-12-31
646,326 GBP2023-12-31
Share premium
20,581,638 GBP2024-12-31
15,205,714 GBP2023-12-31
Retained earnings (accumulated losses)
-19,491,974 GBP2024-12-31
-13,775,390 GBP2023-12-31
Equity
1,831,989 GBP2024-12-31
2,076,650 GBP2023-12-31
Other Debtors
Current
69,725 GBP2024-12-31
186,370 GBP2023-12-31
Prepayments/Accrued Income
Current
23,868 GBP2024-12-31
4,448 GBP2023-12-31
Trade Creditors/Trade Payables
Current
245,455 GBP2024-12-31
69,423 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
71,517 GBP2024-12-31
528,476 GBP2023-12-31
Creditors
Current
316,972 GBP2024-12-31
597,899 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
890,750 shares2024-12-31
890,750 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
22,050,000 shares2024-12-31
22,050,000 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
8,812,003 shares2024-12-31
8,915,518 shares2023-12-31
Par Value of Share
Class 3 ordinary share
0.012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
566,280 shares2024-12-31
566,280 shares2023-12-31
Par Value of Share
Class 4 ordinary share
0.012024-01-01 ~ 2024-12-31
  • KAERUS BIOSCIENCE LIMITED
    Info
    FRAXADEV LIMITED - 2016-11-23
    Registered number 10274924
    2nd Floor 168 Shoreditch High Street, London E1 6RA
    PRIVATE LIMITED COMPANY incorporated on 2016-07-12 (9 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-07-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.